The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Text intervention to minimize time burden of cancer care (TIME).
 
Erin Mary Bange
Consulting or Advisory Role - Flatiron Health
 
Kerry Q. Coughlin
No Relationships to Disclose
 
Wenrui Li
No Relationships to Disclose
 
Timothy J Brown
No Relationships to Disclose
 
Daniel Ragusano
No Relationships to Disclose
 
Eesha Balar
No Relationships to Disclose
 
Dhivya Arasappan
No Relationships to Disclose
 
Michelle Nnaji
No Relationships to Disclose
 
Elliot Kim
No Relationships to Disclose
 
Corey Alban
No Relationships to Disclose
 
Sindhuja Uppuluri
No Relationships to Disclose
 
Lindsey Joan Zinck
No Relationships to Disclose
 
Donna L. Capozzi
No Relationships to Disclose
 
Michael Josephs
No Relationships to Disclose
 
Danielle Zubka
No Relationships to Disclose
 
Roy Rosin
No Relationships to Disclose
 
Mohan Balachandran
Employment - University of Pennsylvania
 
Lawrence N. Shulman
Consulting or Advisory Role - Genentech
Research Funding - Celgene (Inst); Independence Blue Cross (Inst)
 
Carmen Guerra
Stock and Other Ownership Interests - BEAM Therapeutics; crispr therapeutics; Editas Medicine; Intellia Therapeutics
Consulting or Advisory Role - AstraZeneca (I); Guardant Health; Impulse (I)
Speakers' Bureau - Esperion Therapeutics (I); Janssen (I)
Research Funding - Genentech (Inst)
Travel, Accommodations, Expenses - Esperion Therapeutics (I)
 
Ronac Mamtani
Honoraria - Flatiron Health
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Genentech/Roche; Seattle Genetics/Astellas
Research Funding - Astellas Pharma (Inst); Merck